Earnings History Data for Intensity Therapeutics, Inc. (INTS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Intensity Therapeutics, Inc.
Intensity Therapeutics Inc. is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. Intensity leverages its DfuseRx(SM) technology platform to create new, proprietary drug formulations, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity Therapeutics Inc. is based in WESTPORT, Conn.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14-08-2023 | PM | INTS | Intensity Therapeutics, Inc. | 79.25 | -1.43 | 0.00 | 0.00 | Intensity Therapeutics GAAP EPS of -$1.43 misses by $1.03 [8/14/2023 7:52 AM] |
5.92 | -0.19 (-3.06%) |
0.0 | 0.0 (0.00%) |
5.40 - 6.75 | 23,720 | 10,000 | 0 | ||